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Transmission of Zika virus (ZIKV) was first detected 
in Colombia in September 2015. As of April 2016, 
Colombia had reported over 65,000 cases of Zika virus 
disease (ZVD). We analysed daily surveillance data of 
ZVD cases reported to the health authorities of San 
Andres and Girardot, Colombia, between September 
2015 and January 2016. ZVD was laboratory-confirmed 
by reverse transcription-polymerase chain reaction 
(RT-PCR) in the serum of acute cases within five days 
of symptom onset. We use daily incidence data to 
estimate the basic reproductive number (R0) in each 
population. We identified 928 and 1,936 reported ZVD 
cases from San Andres and Girardot, respectively. The 
overall attack rate for reported ZVD was 12.13 cases 
per 1,000 residents of San Andres and 18.43 cases 
per 1,000 residents of Girardot. Attack rates were 
significantly higher in females in both municipalities 
(p < 0.001). Cases occurred in all age groups with high-
est rates in 20 to 49 year-olds. The estimated R0 for the 
Zika outbreak was 1.41 (95% confidence interval (CI): 
1.15–1.74) in San Andres and 4.61 (95% CI: 4.11–5.16) 
in Girardot. Transmission of ZIKV is ongoing in the 
Americas. The estimated R0 from Colombia supports 
the observed rapid spread.
Introduction
First isolated in the Zika Forest of Uganda in 1947, Zika 
virus (ZIKV) is a flavivirus of the same genus as dengue 
virus and yellow fever virus. It is an arbovirus primarily 
transmitted by Aedes aegypti mosquitoes [1]. Although 
ZIKV has circulated in Africa and Asia since the 1950s, 
little is known about its transmission dynamics [2]. 
Recent outbreaks in Yap Island in Micronesia (2007), 
French Polynesia (2013), and other Pacific islands, 
including Cook Islands, Easter Island, and New 
Caledonia (2014), indicate that ZIKV has spread beyond 
its former geographical range [3-6]. In April 2015 ZIKV 
was isolated in the north-east of Brazil [7].
As of June 2016, around 500,000 Zika virus disease 
(ZVD) cases have been estimated in Brazil, and autoch-
thonous circulation has been observed in 40 countries 
in the Americas. Further spread to countries within the 
geographical range of Ae. aegypti mosquitoes is con-
sidered likely [8].
Infection with ZIKV typically causes a self-limited den-
gue-like illness characterised by arthralgia, conjuncti-
vitis, exanthema and low-grade fever [9]. While illness 
is believed to be mild or asymptomatic in ca 80% of 
the infections [10], an increase in rates of Guillain–
Barré syndrome (GBS) has been observed during ZIKV 
outbreaks [8,11,12]. Furthermore, in October 2015, 
the Brazilian Ministry of Health reported a dramatic 
increase in cases of microcephaly in north-east Brazil 
where ZIKV had been circulating [13].
On the basis of the possible link between ZIKV, GBS and 
microcephaly, the World Health Organization (WHO) 
declared a public health emergency on 1 February 2016 
[14,15].
In Colombia, the virus was first detected in mid-Sep-
tember 2015 in a municipality called Turbaco on the 
Caribbean coast. Turbaco is located 10.1 km from 
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Cartagena (ca 20 min drive), a well-known commercial 
and tourism hub (Figure 1).
In October 2015, ZIKV spread through the central 
region of the country, appearing in areas infested with 
Ae. aegypti and with endemic dengue transmission 
and ongoing circulation of chikungunya virus (CHIKV) 
since 2014. By April 2016, Colombia had reported over 
65,000 cases of ZVD, making it the second country 
most affected by ZIKV after Brazil [16,17]. Up to April 
2016, 280 cases of neurological complications includ-
ing GBS as well as seven deaths possibly associated 
with ZVD had been reported in Colombia [18]. As of 
April 2016, there have been four confirmed cases of 
ZIKV congenital syndrome in the country [17].
In this paper we describe local ZIKV outbreaks between 
September 2015 and January 2016 in Girardot and San 
Andres island, two different geographical areas in 
Colombia for which detailed epidemiological data are 
available. We conduct an investigation to define the 
epidemiological features of these outbreaks and to 
estimate the corresponding transmission parameters.
Methods
Settings
San Andres
San Andres is the largest island in a Colombian archi-
pelago in the Caribbean Sea located ca 750 km north 
of mainland Colombia and 230 km east of Nicaragua 
(Figure 1). The island has an area of 27 km2, a popu-
lation of 54,513 inhabitants across 13,652 households, 
and a population density of 2,932 habitants per km2 in 
2010 [19,20]. Tourism is the most important economic 
activity in San Andres, with two high touristic sea-
sons: June to July and December to January. The aver-
age temperature is 27.3 °C, and 80% of the total annual 
rainfall of 1,700 mm occurs during the heavy rainy 
season between October and December. The weather 
is humid subtropical with occasional hurricanes. The 
population in San Andres has two main ethnic groups: 
Afro-Colombians (17.5%) and Raizal (an ethnic group 
of mixed Afro-Caribbean and British descent) (39.2%) 
[20]. The most productive breeding sites of Ae. aegypti 
in San Andres are unprotected water containers located 
in the households. San Andres has experienced low 
dengue transmission (annual incidence rates <1%) since 
1983. Since 1995, the frequency of dengue outbreaks 
increased every two to five years with a mean annual 
incidence of 0.43 cases per 1,000 inhabitants between 
1999 and 2010 [19]. In 2014, CHIKV began circulating 
in San Andres, and that year it reached an annual inci-
dence of 3.65 cases per 1,000 inhabitants [21].
Girardot
Girardot is a very central and well-connected munici-
pality in continental Colombia. It is located 134 km (2 
hours’ drive) from the capital city of Bogota, and it is 
a popular tourist destination for residents of Bogota 
(Figure 1). Girardot has 102,225 inhabitants across ca 
23,000 households based on the most recent census 
from the National Statistics Department (NSD) [22], 
though the population can increase to 300,000 people 
during long weekends and high season holidays (June 
to July and December to January). Between 5 and 12 
October 2015, a national beauty pageant in Girardot 
drew tourists from all regions in Colombia. Girardot 
is 289 m above sea level. The average temperature is 
33.3 °C, and the relative humidity is 66%. The mean 
annual precipitation is 1,220 mm with a rainy season 
extending from May through October [23]. The most 
productive breeding sites of Ae. aegypti in Girardot are 
unprotected private water containers, such as water 
storage tanks used in the households during the dry 
and rainy seasons, while public spaces provide more 
breeding sites during the rainy season [24]. Girardot 
has experienced hyperendemic transmission of den-
gue since 1990 with simultaneous circulation of all four 
serotypes; the mean annual incidence was 5.72 per 
1,000 inhabitants between 1999 and 2010 [19]. In late 
2014, CHIKV started circulating in Girardot and that 
year it reached an annual incidence of 3.94 per 1,000 
inhabitants, while in 2015 the annual incidence was 
4.97 per 1,000 inhabitants [21,25].
Case definition and laboratory analysis
We analysed surveillance data from nine local health-
care sites in San Andres and twenty-two local health-
care sites in Girardot, representing 100% of surveillance 
sites in both locations. Standardised case definitions 
used in both areas were defined by the Ministry of 
Health (MoH) and Colombian National Institute of 
Health (C-NIH) at the beginning of the ZIKV epidemic. 
Figure 1
Location of the two Zika virus outbreak settings 
investigated, Colombia, September 2015–January 2016
Colombia figures in yellow on the map, with a dark square for 
the capital city Bogotá. The two settings of Zika virus disease 
outbreaks investigated in this study are indicated by a star. 
On the map, the city of Cartagena is also shown, because in 
Colombia, Zika virus was first detected ca 10 km from this city, 
before spreading to other locations in the country.
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According to these definitions, a suspected ZVD case is 
a person presenting with body temperature higher than 
37.2 °C, maculopapular exanthema, and one or more of 
the following: arthralgia, headache, malaise, myalgia 
or non-purulent conjunctivitis and who lived or trav-
elled to an area at risk for ZIKV transmission (usually 
below 2,000 m above sea level in Colombia) within 15 
days of symptom onset. A laboratory-confirmed case 
is a suspected case with a ZIKV-positive reverse tran-
scription-polymerase chain reaction (RT-PCR) result 
as determined by the C-NIH virology reference labora-
tory. ZIKV antibody testing was not done in Colombia 
due to high cross-reactivity with other endemic arbo-
viruses. A clinically-confirmed case is defined by the 
Colombian authorities in the same way as a suspected 
case, except that the area of residence or travel within 
15 days of symptom onset is an area with laboratory-
confirmed ZIKV circulation [26].
Because the definition of a clinically-confirmed case in 
Colombia corresponded at the time of the study, to that 
of a probable case according to the WHO classification, 
we further refer to clinically-confirmed cases as prob-
able cases in the context of this report [27].
At the start of the outbreaks in Girardot and San Andres, 
when local circulation of ZIKV had not yet been labora-
tory confirmed, only suspected cases were reported. 
Once the C-NIH confirmed the circulation of ZIKV in 
Girardot (on 27 January 2016, 3 months after the first 
local case report) and San Andres (on 22 October 2015, 
45 days after the first local case report), the samples 
from suspected ZIKV cases were sent for laboratory 
confirmation if the respective cases fell into the risk 
groups defined by the C-NIH, including newborns and 
infants (age < 1 year), persons aged > 65 years, pregnant 
women, and individuals with comorbidities (e.g. dia-
betics, persons who were immunocompromised and/or 
with cardiovascular diseases) [23].
After ZIKV circulation was confirmed in the two areas, 
suspected cases whose acute samples tested positive 
were reclassified as laboratory-confirmed cases, while 
those with samples negative for ZIKV were reclassified 
as non-cases [26]. All reported suspected cases, who 
had not undergone laboratory testing were reclassified 
as probable cases [27]. 
Data collection
The data in San Andres were collected initially using 
the C-NIH standard report form for dengue surveillance 
because from September up to October 2015 the out-
break in San Andres had an unknown aetiology. Once 
the C-NIH declared an alert on 14 October 2015 because 
ZIKV circulation had been observed in other areas of 
Colombia, reporting of ZVD became mandatory in the 
country, after which cases were reported by physicians 
at the healthcare sites using the standard report form 
for ZVD surveillance. The completeness of reporting is 
not known. We analysed a de-identified dataset based 
on place of residence with the following variables: age, 
sex, pregnancy status, date of symptom onset, date 
the case visited the healthcare facility, date the case 
was reported to the national surveillance system, and 
case type (suspected, laboratory confirmed, probable). 
Non-residents were excluded from the data [28].
Statistical analysis
We calculated overall and age/sex-specific attack 
rates using population census data from NSD [22]. 
Figure 2
Daily Zika virus disease incidence in San Andres, Colombia, September 2015–January 2016 (n=928 cases)
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Cases include all reported cases, which were San Andres residents.
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Surveillance data were analysed using R version 3.2.0 
[29]. For descriptive results, categorical variables are 
presented as proportions and continuous variables by 
the median and interquartile range (IQR) or range. The 
relationship between attack rates and the variables 
age and sex was tested using log-linear models for 
case counts with age category (0–19 years-old, 20–49 
years-old and >50 years-old), sex, and an interaction 
between age category and sex as independent vari-
ables, with population size as an offset.
To estimate the basic reproductive number R0 in each 
population, we used maximum likelihood methods 
to fit a chain-binomial model to daily incidence data 
[30]. The model assumes a mean serial interval of 22 
days (time between successive cases in a chain of 
transmission); the serial interval takes into account 
the infectious period in humans, the extrinsic latent 
period in mosquitoes, the mean infectious period 
in the mosquito, and the mean incubation period in 
humans [4,9,31,32]. Underreporting is assumed to be 
high (only 10% of cases reported) at the start of the 
outbreak and full reporting is assumed to be achieved 
in four weeks after the outbreak begins to grow. With 
this assumption, we aimed to take into account the 
respective delays in the two sites, between the ZVD 
outbreak start and the confirmation by the C-NIH of cir-
culation of ZIKV. R0 is the median effective reproduc-
tive number during the growth phase of the epidemic, 
after accounting for early underreporting (see supple-
mentary materials online for additional details on the 
model: https://github.com/dprojas/Zika).
Figure 3
Age- and sex-specific Zika virus disease attack rates for San Andres, Colombia, September 2015–January 2016 (n=928 cases)
Male
Female
25
20
15
10
5
<4
5–
9
10
–1
4
At
ac
k 
ra
te
s 
(p
er
 1,
00
0 
po
pu
la
tio
n)
Age group (years)
15
–1
9
20
–2
4
25
–2
9
30
–3
4
35
–3
9
40
–4
4
45
–4
9
50
–5
4
55
–5
9
60
–6
4
65
–6
9
70
–7
4
75
–7
9
>8
0
0
Figure 4
Daily ZVD incidence for Girardot, Colombia, October 2015–January 2016 (n=1,936 cases)
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Results
San Andres
In San Andres, we identified 928 reported ZVD cases 
(Table 1). Of these cases, 52 (5.6%) were laboratory 
confirmed by RT-PCR on acute phase samples collected 
within five days of symptom onset, and 876 (94.4%) 
cases were probable.
The dates of symptom onset among cases in San 
Andres ranged from 6 September 2015, to 30 January 
2016 (Figure 2). Though the earliest case reported 
symptom onset on 6 September 2015, the local health-
care authorities did not receive laboratory confirmation 
of ZIKV until 22 October 2015. The distribution of this 
outbreak was bimodal. The first wave of the outbreak 
was before the C-NIH made an alert on 14 October 2015, 
about circulation of ZIKV in the country. The second 
wave started after the alert and the number of cases 
peaked in epidemiological week 45 (8 to 14 November), 
before the high tourist season started, and subsided in 
the last week of December. The second wave could be 
due to a reporting phenomenon.
The median time between symptom onset and visiting 
a healthcare facility was 4 days (IQR: 1–16).
Around 79% (733/928) of cases were reported to the 
national surveillance system on the same day that 
they visited the healthcare facility. The median age of 
reported ZVD cases in San Andres was 31 years-old 
(IQR: 15–47 years; range: 12 days–82 years). A total of 
589 (63.5%) of the reported cases occurred in females. 
During the study period 238 dengue cases (incidence 
rate: 4.36 per 1,000 habitants) and 10 CHIKV cases 
(0.18 per 1,000 habitants) were reported in San Andres 
as expected in accordance with the trends and the his-
torical data (data not shown).
The overall attack rate for ZVD reported by local sur-
veillance was 12.13 per 1,000 San Andres residents. 
The sex-specific attack rates were 15.34 per 1,000 
females and 8.91 per 1,000 males; the difference was 
significant adjusting for age (p < 0.001). Cases occurred 
among all age groups, but the incidence of ZVD detected 
by local surveillance was highest among persons 20 to 
49 years-old (Figure 3); there was significant hetero-
geneity across the age groups (p < 0.001). There was a 
significant interaction between age and sex (p < 0.001), 
consistent with the observation that attack rates were 
higher in females across all age groups 10 years-old 
and above, but lower for the younger age groups (Table 
2).
Thirty-three pregnant women with ZVD were reported 
in San Andres and are being followed according to 
national guidelines [33,34]. By June 2016, twenty-eight 
of them had given birth with two probable cases of con-
genital ZIKV syndrome reported. There were eight neu-
rological syndromes reported in San Andres, including 
GBS and meningoencephalitis attributed to ZIKV and 
among them one death was reported. The incidence 
rate of neurological syndromes among ZVD cases in 
San Andres is 8.6 per 1,000 cases.
Girardot
In Girardot, we identified 1,936 reported ZVD cases 
(Table 1). Of these cases, 32 (1.7%) were laboratory 
confirmed by RT-PCR on acute phase samples collected 
within five days of symptom onset and 1,904 (98.3%) 
were probable.
The date of symptom onset among cases in Girardot 
ranged from 19 October 2015 to 22 January 2016 
(Figure 4). The first suspected case was reported on 23 
October 2015, 19 days after the beauty pageant event 
started, with laboratory confirmation obtained on 27 
January 2016. The number of cases peaked in epidemi-
ological week 48 (29 November to 5 December) before 
Figure 5
Age- and sex-specific Zika virus disease attack rates for Girardot, Colombia October 2015–January 2016 (n=1,936 cases)
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Figure 6
Estimates of effective R (red) and model-fitted daily case numbers (green) for outbreaks of Zika virus disease in Colombia, 
September 2015–January 2016 (n=2,864 cases
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the end-of-the-year tourist season, and subsided in 
early January.
The median time between symptom onset and visiting 
a healthcare facility was 1 day (IQR: 1–2 days). Around 
89% (755/1,936) of cases were reported to the national 
surveillance system on the same day they visited the 
healthcare facility. The median age of confirmed ZVD 
cases was 34 years-old (IQR: 24–46 years; range: 15 
days–92 years). A total of 1,138 (58.8%) cases were 
female. During the study period 75 dengue cases (inci-
dence rate: 0.73 per 1,000 habitants) and 200 CHIKV 
cases (1.95 per 1,000 habitants) were reported in 
Girardot as expected in accordance with the trends and 
the historical data (data not shown).
The overall attack rate for confirmed ZVD detected by 
local surveillance was 18.43 per 1,000 Girardot resi-
dents. The sex-specific attack rates were 20.53 per 
1,000 females and 16.07 per 1,000 males; the differ-
ence was significant adjusting for age (p < 0.001). Cases 
occurred among all age groups, but the incidence of 
ZVD detected by local surveillance was highest among 
persons 20 to 49 years-old (Figure 5); there was signif-
icant heterogeneity across the age groups (p < 0.001). 
Attack rates were higher in females in all age groups 
except in those 10 to 14 and 65 to 69 years-old; there 
was no significant interaction between age and sex 
(p = 0.20) (Table 2).
Sixteen pregnant women with ZVD were reported in 
Girardot and are being followed according to national 
guidelines [33,34]. By June 2016, twelve of them had 
given birth with no complications or microcephaly 
reported. Nine cases with GBS have been reported 
after an initial suspected ZIKV infection; laboratory-
confirmation of ZIKV is pending. There were no deaths 
attributed to ZIKV. The incidence rate of neurological 
syndromes among ZVD cases in Girardot is 4.6 per 
1,000 cases.
Basic reproductive number calculations
Daily incidence data were used to estimate R0. The 
estimated R0 for the Zika outbreak in San Andres was 
1.41 (95% confidence interval (CI): 1.15–1.74), and the 
R0 in Girardot was 4.61 (95% CI: 4.11–5.16) (Table 
2 and Figure 6). Odds ratios for sex and age effects 
were obtained from the likelihood model, indicating 
increased odds of transmission among females and 
adults aged 20 to 49 years-old in both San Andres and 
Girardot (Table 2).
The estimation procedure was also applied to daily 
incidence data from a published outbreak in Salvador, 
Brazil, that occurred between 15 February 2015, and 25 
June 2015; 14,835 cases were reported with an overall 
attack rate of 5.5 cases per 1,000 Salvador residents 
[7]. The estimated R0 of the Zika outbreak in Salvador, 
Brazil was 1.42 (95% CI: 1.35–1.49).
Sensitivity analyses are reported in the supplementary 
online materials (https://github.com/dprojas/Zika), 
including varying the incubation period in humans, the 
infectious period in humans, the infectious period in 
mosquitoes, the duration of underreporting, and the 
level of underreporting at the start of the outbreak.
Discussion
We report surveillance data on ZIKV outbreaks in 
two areas in Colombia between September 2015 and 
January 2016. The first area, San Andres, is a small, 
densely populated island that is relatively isolated 
from continental Colombia. The second area, Girardot, 
is a typical moderately sized Colombian municipality. 
Both regions have endemic transmission of dengue and 
experienced recent outbreaks of CHIKV. We describe 
key epidemiological features of the ZVD outbreaks and 
estimate R0 from daily incidence data.
The overall attack rates for ZVD as detected by local 
surveillance were 12.13 cases per 1,000 residents 
of San Andres and 18.43 cases per 1,000 residents 
of Girardot. These attack rates are similar to those 
reported from Yap Island (14.3 per 1,000) [3] but higher 
than those reported in Salvador, Brazil (5.5 per 1,000) 
[7]. In both areas, significantly higher attack rates are 
observed among women, especially those of child-bear-
ing age. The Colombian government issued an epide-
miological alert in December 2015 to actively search for 
pregnant women with ZVD-like symptoms in areas with 
active transmission [33,34]. This effort may partially 
explain the findings, though differences in sex-specific 
Table 1
Characteristics of reported cases of Zika virus disease in two areas of Colombia, September 2015–January 2016
Areas San Andres Girardot
Total number of cases 928 1,936
Laboratory confirmed cases n (%) 52 (5.6%) 32 (1.7%)
Probable cases n (%) 876 (94.4%) 1,904 (98.3%)
Female n (%) 589 (63.5%) 1,138 (58.8%)
Median age in years (IQR) 31 (15–47) 34 (24–46)
Median time in days to visit healthcare facility from symptom onset (IQR) 4 (1–16) 1 (1–2)
IQR: interquartile range.
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attack rates persist when only cases occurring before 
December are considered. These results could be 
explained by male-to-female sexual transmission of 
ZVD, which is consistent with higher attack rates in 
females beyond child-bearing age. Given recent evi-
dence from Brazil, in areas with ZIKV transmission, 
interventions aimed at preventing sexual-transmission 
of ZIKV to women are necessary because this mode 
of transmission could have a substantial influence on 
the overall dynamics of ZIKV epidemics [35-37]. Cases 
occurred in all age groups, but the most affected age 
group was 20 to 49 year of age, similar to previously 
published outbreaks in Yap Island, Micronesia, and in 
Salvador, Brazil [3,7]. As the population was fully sus-
ceptible to ZIKV transmission before the outbreaks, it 
is expected that all age groups would be affected.
Forty-nine pregnant women with ZVD were reported 
from San Andres and Girardot. These women are being 
followed according to national guidelines [33,34] with 
two probable cases of congenital ZIKV syndrome 
reported from San Andres to the national authorities 
for analysis. Seventeen cases of neurological syn-
drome, including GBS and ZIKV-associated menin-
goencephalitis, were identified, similar to reports 
from French Polynesia and Brazil [12,38]. Laboratory-
confirmation of these cases is challenging because 
neurological symptoms generally appear two weeks 
after acute symptoms [39] at which time ZIKV diag-
nosis by RT-PCR is not possible and serological tests 
are unreliable because of cross-reactivity with dengue 
[40,41]. As ZIKV can be detected in urine longer than in 
serum [42], using urine samples to confirm ZIKV in GBS 
cases may be an alternative [43]. These challenges 
underscore the need for reliable diagnostic tests that 
can detect ZIKV after the viraemic period.
In each area of this study, daily incidence data were 
used to estimate R0. Our estimated R0 for the ZVD 
outbreak in San Andres was 1.41 (95% CI: 1.15–1.74), 
and the R0 for Girardot was 4.61 (95% CI: 4.11–5.16). 
Applying the same methods with previously published 
data, we estimated that the R0 for ZIKV in Salvador, 
Brazil, was 1.42 (95% CI: 1.35–1.49) [7]. We consider 
the estimate from San Andres to be the most reliable 
because it is a small, densely populated island and the 
outbreak occurred before the national epidemiological 
alert, while Girardot has a higher risk of importation 
because the population fluctuates during weekends 
and holidays. The relative magnitudes of R0 are con-
sistent with the higher dengue transmission histori-
cally observed in Girardot vs San Andres [19].
Estimates of R0 in ZIKV are not widely available, though 
reports suggest an R0 of 4.3 to 5.8 in Yap Island and R0 
of 1.8 to 2.0 in French Polynesia [44]. A recent manu-
script considering the French Polynesian outbreak 
reported a range from 1.9 to 3.1 [45].
Relatively few cases were laboratory confirmed. One 
limitation of this study is that the majority of cases were 
probable, and the symptoms could be caused by other 
aetiologies such as dengue or CHIKV. Nonetheless, 
in the field we have observed that the diseases have 
different clinical manifestations. Dengue appears to 
coincide with high fever (> 38.5 °C), headaches, myal-
gia, and generalised pain. CHIKV is associated with 
joint pain and arthritis, and ZVD is associated with a 
very mild, low-grade fever (38 °C) or no fever, rash, 
and no generalised pain. This report only includes 
symptomatic cases who attended a healthcare facility 
and were captured by the surveillance systems. ZIKV 
usually causes a relatively mild illness lasting sev-
eral days, and around 80% of infections are currently 
believed to be asymptomatic, so we are likely miss-
ing many mild or asymptomatic cases [10]. We also do 
not have a reliable estimate of underreporting at the 
study sites. Early underreporting seemed to be espe-
cially apparent in the Girardot outbreak compared with 
San Andres given that the circulation of ZIKV was not 
confirmed until January, 2016, and the sharp increase 
in cases in Girardot observed may be due to increased 
public awareness of the disease. This phenomenon can 
result in an overestimate of R0.
Well-designed studies can provide valuable insight. 
Phylogenetic analyses of circulating ZIKV strains will 
be critical for understanding whether mutations in the 
viral genome are associated with an increased sever-
ity of disease, as manifested by microcephaly and 
GBS in this outbreak. Household studies can allow for 
more accurate estimation of transmission dynamics 
and enhance understanding of asymptomatic infection. 
Studies are required to understand the interactions 
between ZIKV, dengue, CHIKV, and other co-circu-
lating arboviruses and their impact on disease. It is 
also necessary to increase surveillance of neurologi-
cal syndromes associated with ZVD, such as GBS and 
encephalitis.
The evidence for a causal relationship between ZIKV 
and microcephaly is strengthening [46-48]. Recent evi-
dence from the French Polynesia outbreak suggests 
Table 2
Estimates of basic reproductive number (R0), sex-specific odds ratios (OR) and age-specific OR for transmission of 
Zika virus disease in San Andres and Girardot, Colombia, 
September 2015–January 2016
Parameter
Estimate (95%CI) 
San Andres Girardot
Estimate (95%CI)
R0 1.41 (1.15–1.74) 4.61 (4.11–5.16)
OR sex
Male Reference Reference
Female 1.71 (1.50–1.95) 1.28 (1.17–1.40)
OR age in years
20–49 Reference Reference
0–19 0.86 (0.74–0.99) 0.37 (0.33–0.42)
> 50 0.74 (0.63–0.88) 0.46 (0.41–0.52)
CI: confidence interval.
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an estimated number of microcephaly cases possibly 
associated with ZIKV infection is around one per 100 
women infected in the first trimester [49]. Currently the 
Colombian Government is following a cohort of preg-
nant women that reported ZVD-like symptoms anytime 
during their pregnancy. Those who are detected during 
the acute phase are being diagnosed with ZIKV RT-PCR. 
All women will be followed until the end of pregnancy, 
and the fetus will be evaluated during pregnancy, with 
a subsequent post-natal follow-up of twelve months 
[17]. The prospective collection of data through this 
and other similar national cohorts will be essential for 
assessing causality, determining risk factors, and esti-
mating rates of birth defects.
The results of this and other reports conclude that 
transmission of ZIKV may be widespread. Vector con-
trol has had limited success in controlling other arbovi-
ruses, such as dengue. A safe and efficacious vaccine, 
especially for women of child-bearing age, may be 
needed to reduce the disease burden.
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